4//SEC Filing
Fruchtman Steven M 4
Accession 0001415889-24-003204
CIK 0001130598other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:36 PM ET
Size
8.7 KB
Accession
0001415889-24-003204
Insider Transaction Report
Form 4
Fruchtman Steven M
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-07−21,320→ 21,320 total→ Common Stock (21,320 underlying) - Exercise/Conversion
Common Stock
2024-02-07+21,320→ 69,620 total - Tax Payment
Common Stock
2024-02-07$0.67/sh−9,212$6,172→ 60,408 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On February 7, 2022 the reporting person was granted 63,960 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
Related Parties
1- filerCIK 0001631251
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 5:36 PM ET
- Size
- 8.7 KB